We still Hope
The Women’s Health Clinical Research Center at Penn Medicine is currently recruiting participants with sickle cell disease for a paid study looking at whether participants experience any difference in their sickle cell pain while using a hormonal birth control implant as compared to when not using this birth control method. The implant, known as Nexplanon, is currently FDA approved, releases a small amount of hormone every day, and is the most effective form of hormonal…
ContinueAdded by Katie on June 16, 2023 at 3:58pm — No Comments
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
© 2024 Created by Ade Dotun. Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service